182 related articles for article (PubMed ID: 2657745)
1. Allorecognition of DR1 by T cells from a DR4/DRw13 responder mimics self-restricted recognition of endogenous peptides.
Lombardi G; Sidhu S; Batchelor JR; Lechler RI
Proc Natl Acad Sci U S A; 1989 Jun; 86(11):4190-4. PubMed ID: 2657745
[TBL] [Abstract][Full Text] [Related]
2. Molecular mimicry by major histocompatibility complex molecules and peptides accounts for some alloresponses.
Lechler RI; Heaton T; Barber L; Bal V; Batchelor JR; Lombardi G
Immunol Lett; 1992 Sep; 34(1):63-9. PubMed ID: 1478706
[TBL] [Abstract][Full Text] [Related]
3. Nonrandom selection of T cell specificities in anti-HLA-DR responses. Sequence motifs of the responder HLA-DR allele influence T cell recruitment.
Weyand CM; Hicok KC; Goronzy JJ
J Immunol; 1991 Jul; 147(1):70-8. PubMed ID: 2051028
[TBL] [Abstract][Full Text] [Related]
4. The relationship between MHC restricted and allospecific T cell recognition.
Lechler R; Batchelor R; Lombardi G
Immunol Lett; 1991 Jul; 29(1-2):41-50. PubMed ID: 1916923
[TBL] [Abstract][Full Text] [Related]
5. Human T cells cannot act as autonomous antigen-presenting cells, but induce tolerance in antigen-specific and alloreactive responder cells.
Sidhu S; Deacock S; Bal V; Batchelor JR; Lombardi G; Lechler RI
J Exp Med; 1992 Sep; 176(3):875-80. PubMed ID: 1512550
[TBL] [Abstract][Full Text] [Related]
6. Allo-cross-reactivity of a human neuraminidase-specific T cell clone dependent on presentation of an endogenous B cell-specific antigen.
Kuijpers KC; Treep-Van Leeuwen P; Miedema F; Lucas CJ
Eur J Immunol; 1991 Jun; 21(6):1453-60. PubMed ID: 1710566
[TBL] [Abstract][Full Text] [Related]
7. The specificity of alloreactive T cells is determined by MHC polymorphisms which contact the T cell receptor and which influence peptide binding.
Lombardi G; Barber L; Sidhu S; Batchelor JR; Lechler RI
Int Immunol; 1991 Aug; 3(8):769-75. PubMed ID: 1911546
[TBL] [Abstract][Full Text] [Related]
8. Human TCR-gamma/delta alloreactive response to HLA-DR molecules. Comparison with response of TCR-alpha/beta.
Flament C; Benmerah A; Bonneville M; Triebel F; Mami-Chouaib F
J Immunol; 1994 Oct; 153(7):2890-904. PubMed ID: 8089476
[TBL] [Abstract][Full Text] [Related]
9. Position 71 in the alpha helix of the DR beta domain is predicted to influence peptide binding and plays a central role in allorecognition.
Coppin HL; Carmichael P; Lombardi G; L'Faqihi FE; Salter R; Parham P; Lechler RI; de Preval C
Eur J Immunol; 1993 Feb; 23(2):343-9. PubMed ID: 8436170
[TBL] [Abstract][Full Text] [Related]
10. Co-recognition of endogenous antigens with HLA-DR1 by alloreactive human T cell clones.
Lombardi G; Sidhu S; Lamb JR; Batchelor JR; Lechler RI
J Immunol; 1989 Feb; 142(3):753-9. PubMed ID: 2492329
[TBL] [Abstract][Full Text] [Related]
11. Functional evidence for the recognition of endogenous peptides by autoreactive T cell clones.
Rees AD; Lombardi G; Scoging A; Barber L; Mitchell D; Lamb J; Lechler R
Int Immunol; 1989; 1(6):624-30. PubMed ID: 2489049
[TBL] [Abstract][Full Text] [Related]
12. Structural analysis of anti-DR1 allorecognition by using DR1/H-2Ek hybrid molecules. Influence of the beta 2-domain correlates with CD4 dependence.
Lombardi G; Barber L; Aichinger G; Heaton T; Sidhu S; Batchelor JR; Lechler RI
J Immunol; 1991 Sep; 147(6):2034-40. PubMed ID: 1716292
[TBL] [Abstract][Full Text] [Related]
13. HLA-DR peptide-induced alloreactive T cell lines reveal an HLA-DR sequence that can be both "dominant" and "cryptic": evidence for allele-specific processing.
de Koster HS; van Rood JJ; Termijtelen A
Eur J Immunol; 1992 Jun; 22(6):1531-9. PubMed ID: 1376262
[TBL] [Abstract][Full Text] [Related]
14. Comparison of TCR-alpha beta sequences of cross-reactive anti-DR alloreactive T-cell clones: identification of possible contact residues based on charge complementarity between TCR chains and DR determinants.
Champagne E; Essaket S; Huchenq A; Fabron J; Coppin HL; Sevin J; Thomsen M
Eur J Immunogenet; 1992; 19(1-2):21-31. PubMed ID: 1533151
[TBL] [Abstract][Full Text] [Related]
15. T cell recognition of self-human histocompatibility leukocyte antigens (HLA)-DR peptides in context of syngeneic HLA-DR molecules.
Liu Z; Sun YK; Xi YP; Harris P; Suciu-Foca N
J Exp Med; 1992 Jun; 175(6):1663-8. PubMed ID: 1375267
[TBL] [Abstract][Full Text] [Related]
16. Different regions of the N-terminal domains of HLA-DR1 influence recognition of individual peptide-DR1 complexes.
Tuosto L; Karr RW; Fu XT; Olson RR; Cundari E; Piccolella E; Lechler R; Lombardi G
Hum Immunol; 1994 Aug; 40(4):312-22. PubMed ID: 7528190
[TBL] [Abstract][Full Text] [Related]
17. Differential effect of polymorphism at HLA-DR1 beta-chain positions 85 and 86 on binding and recognition of DR1-restricted antigenic peptides.
Newton-Nash DK; Eckels DD
J Immunol; 1993 Mar; 150(5):1813-21. PubMed ID: 7679697
[TBL] [Abstract][Full Text] [Related]
18. T cell recognition of allopeptides in context of syngeneic MHC.
Liu Z; Braunstein NS; Suciu-Foca N
J Immunol; 1992 Jan; 148(1):35-40. PubMed ID: 1530797
[TBL] [Abstract][Full Text] [Related]
19. Allogeneic recognition of HLA-DRB1*0406 by T cells with HLA-DRB1*0403: role of amino acid residue 37 on the beta sheet in T cell recognition.
Kaneko T; Obata F
Immunobiology; 1996 Aug; 195(3):261-70. PubMed ID: 8877401
[TBL] [Abstract][Full Text] [Related]
20. A novel T-cell-defined HLA-DR polymorphism not predicted from the linear amino acid sequence.
Termijtelen A; van den Elsen P; Koning F; de Koster S; Schroeijers W; Vanderkerckhove B
Hum Immunol; 1989 Sep; 26(1):47-58. PubMed ID: 2476425
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
